AB Science is up over 5% after the pharmaceutical company announced that it had successfully appealed to the Paris Court of Appeal against the decision of the AMF's Enforcement Committee on March 24, 2022.

This 2022 decision had dismissed the company's CEO Alain Moussy for alleged insider trading and sanctioned AB Science for failing to meet certain disclosure obligations.

The Paris Court of Appeal confirmed that Alain Moussy had been fully exonerated, and reduced the fine imposed on AB Science by 200,000 euros, 200,000 euros of which will have to be reimbursed by the French Treasury.

Copyright (c) 2024 CercleFinance.com. All rights reserved.